Suppr超能文献

抗VEGF发夹状核酶基因抑制VEGF表达及卵巢癌细胞增殖的实验研究

[Experimental study of anti-VEGF hairpin ribozyme gene inhibiting expression of VEGF and proliferation of ovarian cancer cells].

作者信息

Yan Rui-lan, Qian Xin-hua, Xin Xiao-yan, Jin Ming, Hui Hong-xiang, Wang De-tang, Wang Jian

机构信息

Department of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, P. R. China.

出版信息

Ai Zheng. 2002 Jan;21(1):39-44.

Abstract

BACKGROUND & OBJECTIVE: Growth of solid tumor metastases are critically dependent on angiogenesis. Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, has been identified as one of the most potent inducers of tumor associated angiogenesis, studies have shown that VEGF plays an important role in angiogenesis which is associated with epithelial ovarian cancer. Until now, many strategies for gene therapy have been developed. Among them is Ribozyme-based therapeutics for cancer which might be devised to inhibit tumor growth or prevent metastases. Angiogenesis is required for sustained tumor growth, making the VEGF pathway another promising target for either small molecule or nucleic acid-based therapeutics. Little is known about the role of VEGF in ovarian tumorigenecity. We propose to block the autocrine and/or paracrine pathway of VEGF in ovarian cancer using anti-VEGF hairpin ribozyme gene to see whether the growth of tumor cells could be inhibited and to further exploit its mechanisms.

METHODS

Anti-VEGF hairpin ribozyme gene eukaryotic expression vector was introduced into ovarian cancer SKOV3 cells by lipofectin mediation and positive clones were screened by G418; Ribozyme expression was confirmed by RNA dot blot; The VEGF expression of SKOV3 cells before or after transfection were detected by immunohistochemical and immunofluorescence and flow cytometer immunofluorescence methods, MTT, colony forming, soft agar colony forming, and FCM were used to observe the effect of proliferation to ovarian cancer cells.

RESULTS

VEGF expression decreased distinctly in SKOV3-RZ cells. The growth of transfected SKOV3-RZ cells were slower, The average colony forming efficiency and soft agar colony forming efficiency of SKOV3-RZ cells(12.7 +/- 1.4 and 9.4 +/- 2.0, respectively) decreased distinctly (P < 0.001). The SKOV3-RZ cells of G1 stage increased(P < 0.01), the SKOV3-RZ cells of S stage were reduced(P < 0.01).

CONCLUSIONS

Anti-VEGF hairpin ribozyme gene can inhibit the proliferation of ovarian cancer SKOV3 cells. This provides a experimental basis for cure human ovarian cancer with antiangiogenesis method.

摘要

背景与目的

实体瘤转移灶的生长严重依赖于血管生成。血管内皮生长因子(VEGF),也被称为血管通透因子,已被确定为肿瘤相关血管生成的最有效诱导剂之一。研究表明,VEGF在与上皮性卵巢癌相关的血管生成中起重要作用。到目前为止,已经开发了许多基因治疗策略。其中基于核酶的癌症治疗方法可能被设计用于抑制肿瘤生长或预防转移。持续的肿瘤生长需要血管生成,这使得VEGF途径成为小分子或基于核酸的治疗方法的另一个有前景的靶点。关于VEGF在卵巢肿瘤发生中的作用知之甚少。我们建议使用抗VEGF发夹核酶基因阻断卵巢癌中VEGF的自分泌和/或旁分泌途径,以观察肿瘤细胞的生长是否可以被抑制,并进一步探讨其机制。

方法

通过脂质体介导将抗VEGF发夹核酶基因真核表达载体导入卵巢癌SKOV3细胞,并用G418筛选阳性克隆;通过RNA斑点印迹法确认核酶表达;采用免疫组织化学、免疫荧光和流式细胞仪免疫荧光方法检测转染前后SKOV3细胞的VEGF表达,采用MTT、集落形成、软琼脂集落形成和FCM观察对卵巢癌细胞增殖的影响。

结果

SKOV3-RZ细胞中VEGF表达明显降低。转染后的SKOV3-RZ细胞生长较慢,SKOV3-RZ细胞的平均集落形成效率和软琼脂集落形成效率(分别为12.7±1.4和9.4±2.0)明显降低(P<0.001)。G1期的SKOV3-RZ细胞增加(P<0.01),S期的SKOV3-RZ细胞减少(P<0.01)。

结论

抗VEGF发夹核酶基因可抑制卵巢癌SKOV3细胞的增殖。这为用抗血管生成方法治疗人类卵巢癌提供了实验依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验